Psychiatry Research
Volume 137, Issue 3 , Pages 183-190 , 15 December 2005

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

  • Johanna Palmio

      Affiliations

    • Department of Neurology, University of Tampere, FIN-33014, Tampere, Finland
    • Department of Neurology, Tampere University Hospital, Tampere, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 3 355111; fax: +358 3 35516164.
    • ,
  • Martti Huuhka

      Affiliations

    • Department of Psychiatry, Tampere University Hospital, Tampere, Finland
    • ,
  • Pirjo Saransaari

      Affiliations

    • Brain Research Center, University of Tampere, Tampere, Finland
    • ,
  • Simo S. Oja

      Affiliations

    • Brain Research Center, University of Tampere, Tampere, Finland
    • Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
    • ,
  • Jukka Peltola

      Affiliations

    • Department of Neurology, Tampere University Hospital, Tampere, Finland
    • ,
  • Esa Leinonen

      Affiliations

    • Department of Psychiatry, Tampere University Hospital, Tampere, Finland
    • ,
  • Jaana Suhonen

      Affiliations

    • Department of Neurology, Central Hospital, Jyväskylä, Finland
    • ,
  • Tapani Keränen

      Affiliations

    • Department of Neurology, Tampere University Hospital, Tampere, Finland

Received 5 October 2004 ,Revised 1 July 2005 ,Accepted 15 July 2005.

References 

  1. Altamura C, Maes M, Dai J, Meltzer HY. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. European Neuropsychopharmacology. 1995;5:S71–S75
  2. Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F. Plasma and platelet excitatory amino acids in psychiatric disorders. American Journal of Psychiatry. 1993;150:1731–1733
  3. American Psychiatric Association . Task Force Report. Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. Washington, DC: APA; 1990;
  4. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  5. Angehelascu I, Klawe CJ, Bartensstein P, Szegedi A. Normal PET after long-term ECT. American Journal of Psychiatry. 2001;158:1527;(Letter)
  6. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry. 2000;47:305–313
  7. Bergsholm P, Larsen JL, Rosendahl K, Holsten F. Electroconvulsive therapy and cerebral computed tomography. Acta Psychiatrica Scandinavica. 1989;80:566–567
  8. Berk M, Plein H, Belsham B. The specificity of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sciences. 2000;66:2427–2432
  9. Berk M, Plein H, Ferreira D. Platelet glutamate receptor supersensitivity in major depressive disorder. Clinical Neuropharmacology. 2001;24:129–132
  10. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Molecular Psychiatry. 2003;8:721–737
  11. Calev A, Cohen R, Tubi N, Nigal D, Shapira B, Kugelmass S, et al. Disorientation and bilateral moderately suprathreshold titrated ECT. Convulsive Therapy. 1991;7:99–110
  12. Castillo J, Davalos A, Naveiro J, Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996;27:1060–1065
  13. Chamberlin E, Tsai GE. A glutamatergic model of ECT-induced memory dysfunction. Harvard Review of Psychiatry. 1998;5:307–317
  14. Coffey CE, Weiner RD, Djang WT, Figiel GS, Soady SA, Patterson LJ, et al. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Archives of General Psychiatry. 1991;48:1013–1021
  15. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure?. American Journal of Psychiatry. 1994;151:957–970
  16. Devanand D, Shapira B, Petty F, Kramer G, Fitzsimons L, Lerer B, et al. Effects of electroconvulsive therapy on plasma GABA. Convulsive Therapy. 1995;11:3–13
  17. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic spectroscopic imaging study. Archives of General Psychiatry. 2000;57:937–943
  18. Ferraro TN, Golden GT, Hare TA. Repeated electroconvulsive shock selectively alters γ-aminobutyric acid levels in the rat brain: effect of electrode placement. Convulsive Therapy. 1990;6:199–208
  19. Hoekstra R, van den Broek WW, Fekkes D, Bruijn JA, Mulder PGH, Peppelinkhuizen L. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Research. 2001;103:115–123
  20. Heresco-Levy U. Amino acid transmitter systems in schizophrenia and other psychotic disorders. In:  D'haenen H,  den Boer JA,  Westenberg M,  Willner P editor. Biological Psychiatry. London: John Wiley and Sons; 2002;p. 587–600
  21. Ketter TA, Wang PW. The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders. Journal of Clinical Psychiatry. 2003;64:S15–S20
  22. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry. 2002;7:S71–S80
  23. Maes M, Suy E, Minner B. Increased plasma serine in depression. Neuropsychobiology. 1995;31:10–15
  24. Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpé S. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatrica Scandinavica. 1998;97:302–308
  25. Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M, et al. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology. 1998;37:124–129
  26. Miao N, Nagao K, Lynch C. Thiopental and methohexital depress Ca2+ entry into and glutamate release from cultured neurons. Anesthesiology. 1998;88:1643–1653
  27. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychological Medicine. 2003;33:1277–1284
  28. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology. 2003;28:720–725
  29. Mokhtar A, Morgan C, Bradley D, Badawy A. No early effects of electroconvulsive therapy on tryptophan metabolism and disposition in endogenous depression. Biological Psychiatry. 1997;42:201–205
  30. Oja SS, Saransaari P. Taurine as osmoregulator and neuromodulator in the brain. Metabolic Brain Disease. 1996;11:153–164
  31. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Research: Neuroimaging. 2003;122:185–192
  32. Puri BK, Oatridge A, Saeed N, Ging JE, McKee HM, Lekh SK, et al. Does electroconvulsive therapy lead to changes in cerebral structure?. British Journal of Psychiatry. 1998;173:267;(Correspondence)
  33. Rainesalo S, Keränen T, Palmio J, Peltola J, Oja SS, Saransaari P. Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochemical Research. 2004;29:319–324
  34. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine. 1993;328:839–846
  35. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OAC, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Archives of General Psychiatry. 1999;56:1043–1047
  36. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. American Journal of Psychiatry. 2003;160:577–579
  37. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry. 2004;61:705–713
  38. Sumiyoshi T, Anil AE, Jin D, Jayathilake K, Lee M, Meltzer HY. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms. International Journal of Neuropsychopharmacology. 2004;7:1–8
  39. Swartz CM, Abrams R. ECT Instruction Manual. 6th ed.. Lake Bluff, IL: Somatics Inc.; 1996;
  40. Tunnicliff G, Malatynska E. Central GABAergic systems and depressive illness. Neurochemical Research. 2003;28:965–976
  41. Velly LJ, Guillet BA, Masmejean FM, Nieoullon AL, Bruder NJ, Gouin FM, et al. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures. Anesthesiology. 2003;99:368–375
  42. Wahlund B, von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology. 2003;28:S21–S26
  43. Waziri R, Wilcox J, Sherman AD, Mott J. Serine metabolism and psychosis. Psychiatry Research. 1984;12:121–136

PII: S0165-1781(05)00213-1

doi: 10.1016/j.psychres.2005.07.010

Psychiatry Research
Volume 137, Issue 3 , Pages 183-190 , 15 December 2005

Article Tools

* Image Usage & Resolution